Meghmani Organics Limited
Commodities›Chemicals›Fertilizers & Agrochemicals›Pesticides & Agrochemicals
Key metrics
Price as of 2026-07-17
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 426 Cr | 804 Cr | 1,156 Cr | 1,566 Cr | 414 Cr | 958 Cr | 569 Cr | 553 Cr | 614 Cr | 577 Cr | 509 Cr | 474 Cr |
| Operating expenses (approx.) | 441 Cr | 800 Cr | 1,150 Cr | 1,549 Cr | 399 Cr | 900 Cr | 519 Cr | 474 Cr | 530 Cr | 497 Cr | 456 Cr | 417 Cr |
| EBITDA | -15 Cr | 5 Cr | 6 Cr | 17 Cr | 15 Cr | 57 Cr | 50 Cr | 79 Cr | 83 Cr | 80 Cr | 53 Cr | 57 Cr |
| OPM % | -3.5% | 0.6% | 0.6% | 1.1% | 3.6% | 6.0% | 8.8% | 14.3% | 13.6% | 13.8% | 10.3% | 12.0% |
| Other income | 7 Cr | 19 Cr | 29 Cr | 38 Cr | 9 Cr | 21 Cr | 9 Cr | 14 Cr | 17 Cr | 28 Cr | 15 Cr | 37 Cr |
| Interest | 4 Cr | 17 Cr | 44 Cr | 46 Cr | 11 Cr | 37 Cr | 13 Cr | 19 Cr | 29 Cr | 24 Cr | 18 Cr | 20 Cr |
| Depreciation | 24 Cr | 46 Cr | 69 Cr | 92 Cr | 23 Cr | 49 Cr | 30 Cr | 29 Cr | 30 Cr | 30 Cr | 30 Cr | 29 Cr |
| Profit before tax | -43 Cr | -59 Cr | -107 Cr | -121 Cr | -19 Cr | -28 Cr | 7 Cr | 31 Cr | 24 Cr | 26 Cr | 5 Cr | 7 Cr |
| Tax % | 20.0% | 15.4% | 17.6% | 12.5% | 13.3% | 8.6% | 159.3% | 35.1% | 47.8% | 55.7% | 178.3% | -12.4% |
| Net profit | -34 Cr | -50 Cr | -88 Cr | -106 Cr | -17 Cr | -26 Cr | -4 Cr | 20 Cr | 13 Cr | 12 Cr | -4 Cr | 8 Cr |
| EPS (₹) | ₹-1.36 | ₹-1.96 | ₹-3.46 | ₹-4.17 | ₹-0.25 | ₹-1.02 | ₹-0.17 | ₹0.78 | ₹0.50 | ₹0.45 | ₹-0.14 | ₹0.32 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Sales | 2,498 Cr | 2,553 Cr | 1,566 Cr | 2,080 Cr | 2,174 Cr | Sign in for TTM |
| Operating expenses (approx.) | 2,018 Cr | 2,193 Cr | 1,587 Cr | 1,893 Cr | 1,901 Cr | Sign in for TTM |
| EBITDA | 481 Cr | 360 Cr | -20 Cr | 187 Cr | 273 Cr | Sign in for TTM |
| OPM % | 19.2% | 14.1% | -1.3% | 9.0% | 12.6% | Sign in for TTM |
| Other income | 96 Cr | 96 Cr | 38 Cr | 44 Cr | 96 Cr | Sign in for TTM |
| Interest | 9 Cr | 66 Cr | 46 Cr | 69 Cr | 92 Cr | Sign in for TTM |
| Depreciation | 63 Cr | 77 Cr | 92 Cr | 108 Cr | 119 Cr | Sign in for TTM |
| Profit before tax | 409 Cr | 313 Cr | -121 Cr | 9 Cr | 62 Cr | Sign in for TTM |
| Tax % | 25.5% | 24.1% | 12.5% | 211.9% | 53.7% | Sign in for TTM |
| Net profit | 304 Cr | 238 Cr | -106 Cr | -11 Cr | 29 Cr | Sign in for TTM |
| EPS (₹) | ₹11.97 | ₹9.35 | ₹-4.17 | ₹-0.42 | ₹1.13 | Sign in for TTM |
| Dividend payout % | 11.7% | 15.0% | — | — | 0.0% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity capital | 25 Cr | 25 Cr | 25 Cr | 25 Cr | 25 Cr |
| Reserves | 1,441 Cr | 1,644 Cr | 1,502 Cr | 1,490 Cr | 1,519 Cr |
| Borrowings | — | 820 Cr | 835 Cr | 546 Cr | 565 Cr |
| Other liabilities | 1,331 Cr | 709 Cr | 678 Cr | 1,024 Cr | 911 Cr |
| Total liabilities | 2,798 Cr | 3,198 Cr | 3,040 Cr | 3,085 Cr | 3,021 Cr |
| Fixed assets (net) | — | 1,164 Cr | 1,150 Cr | 1,563 Cr | 1,484 Cr |
| CWIP | — | 346 Cr | 509 Cr | 77 Cr | 79 Cr |
| Investments | — | 183 Cr | 114 Cr | 3 Cr | 5 Cr |
| Other assets | — | 1,466 Cr | 1,213 Cr | 1,351 Cr | 1,316 Cr |
| Total assets | 2,798 Cr | 3,198 Cr | 3,040 Cr | 3,085 Cr | 3,021 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Cash from operating activity | 65 Cr | 204 Cr | 250 Cr | 66 Cr | 222 Cr |
| Cash from investing | -133 Cr | -418 Cr | -178 Cr | 31 Cr | -38 Cr |
| Cash from financing | 58 Cr | 234 Cr | -85 Cr | -91 Cr | -190 Cr |
| Net cash flow | -10 Cr | 21 Cr | -14 Cr | 6 Cr | -7 Cr |
| Free cash flow (OCF − Capex) | -179 Cr | -261 Cr | -17 Cr | -23 Cr | 177 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| ROCE % | 28.5% | 11.4% | -4.8% | 3.8% | 7.3% |
| ROE % | 20.8% | 14.2% | -6.9% | -0.7% | 1.9% |
| Debtor days | — | 75 | 101 | — | — |
| Inventory days | — | 156 | 209 | 170 | 154 |
| Days payable | — | 107 | 199 | — | — |
| Cash conversion cycle | — | 124 | 110 | 170 | 154 |
| Debt / equity | — | 0.49 | 0.55 | 0.36 | 0.37 |
| Current ratio | — | 1.42 | 1.15 | 1.12 | 1.07 |
| Net debt / EBITDA | 0.00 | 2.19 | — | 2.80 | 2.01 |
Compare with peers
Loading peers…